Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Manske

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Haematologica|December 7, 2023
MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesisKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
Haematologica|December 4, 2025
Multi-omics analysis reveals a unique epigenetic signature in MYD88 wild-type Waldenstrom macroglobulinemiaKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
Blood Cancer Journal|September 1, 2019
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphomaYucai Wang, Kerstin Wenzl, Michelle K Manske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal GammopathiesPatrizia Mondello, Jonas Paludo, Joseph P Novak, et al.
Blood|July 5, 2024
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylationKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Hematological Oncology|May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomasMelissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Blood Cancer Journal|October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomasMelissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
American Journal of Hematology|January 3, 2022
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester diseaseJithma P Abeykoon, Terra L Lasho, Surendra Dasari, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Haematologica|December 7, 2023
MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesisKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
Haematologica|December 4, 2025
Multi-omics analysis reveals a unique epigenetic signature in MYD88 wild-type Waldenstrom macroglobulinemiaKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
Blood Cancer Journal|September 1, 2019
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphomaYucai Wang, Kerstin Wenzl, Michelle K Manske, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal GammopathiesPatrizia Mondello, Jonas Paludo, Joseph P Novak, et al.
Blood|July 5, 2024
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylationKaran Chohan, Jonas Paludo, Surendra Dasari, et al.
Cell Reports. Medicine|March 1, 2024
Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironmentsJordan E Krull, Kerstin Wenzl, Melissa A Hopper, et al.
Hematological Oncology|May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomasMelissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Blood Cancer Journal|October 9, 2024
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomasMelissa A Hopper, Abigail R Dropik, Janek S Walker, et al.
American Journal of Hematology|January 3, 2022
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester diseaseJithma P Abeykoon, Terra L Lasho, Surendra Dasari, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
Pageof 3